Acromec Engineers has helped its incubator affiliate create a co-working establishment for medtech, biotech and foodtech startups’ R&D initiatives.

Oxygen therapy developer Aviv Scientific completed a $40m series B round led by Danel while drug delivery system developer Credence raised almost as much.

UOB Venture Management led a $30m round for social commerce platform developer Evermos while Advanced Farm Technologies and Nex each bagged $25m.

Sanofi, Axa, Aviva, Pro BTP and CNP Assurances were among the backers of the vehicle, which will focus on biotech investments.

The diabetes management system developer, a spinoff of Sarnoff Corporation, has filed to raise up to $75m in a Nasdaq offering.

Great Hill Partners supplied the series F funding for the McKesson Ventures-backed infusion network operator.

The mobile health app developer's series C round was led by Susquehanna International Group and also featured Horizon Healthcare Services.

Oracle has committed $205m to an initial public offering for the DNA sequencing technology developer with a $410m target for its close.

Illumina has anchored the second fund to be closed by the venture firm it sponsors, with Ireland Strategic Investment Fund among the limited partners.

The cancer treatment developer is set to go public in an offering which would represent exits for Pfizer Ventures, Leaps by Bayer and Ipsen.